Bariatric Times - Supplement A - Covidien - (Page 7) THE 2007 INTERNATIONAL CONSENSUS SUMMIT ON SLEEVE GASTRECTOMY The Relationship Between the Resected Remnant and Weight Loss by RUDOLPH A. WEINER, MD, PhD AUTHOR AFFILIATION: Dr. Weiner is Head of the Department of Surgery, Krankenhaus Sachsenhausen, 60594 Frankfurt am Main, Germany. ADDRESS CORRESPONDENCE TO: Dr. Rudolph A. Weiner, Schulstr. 31, 60594 Frankfurt am Main, Germany; Phone: (49) 69 6605 1133; Fax: (49) 69 6605 1510; E-mail: rweiner@khs-ffm.de BACKGROUND Although the efficacy of laparoscopic sleeve gastrectomy (LSG) for morbidly obese patients with a body mass index (BMI) of greater than 50kg/m2 and the incidence of weight gain by changing of eating behaviors and gastric dilatation following LSG have not been investigated so far, LSG is becoming more common as a single-stage surgical procedure for the treatment of morbidly obese patients. METHODS From March 1994 to March 2007, 3,324 weight loss surgeries were performed in our department. In 2001, the LSG was offered to our patients as part of a two-stage operation, particularly if they were super obese (BMI>60), because it allows the patient to lose enough weight that the risks of the more radical surgery are reduced. Therefore, LSG as the first step of laparoscopic biliopancreatic diversion-duodenal switch (BPDDS) for patients with high BMI was introduced into our bariatric program. From March 2001 to March 2007, a total of 120 LSG procedures were performed. The demographic data are shown in Table 1. Preoperative evaluation of the patients revealed 118 patients (98.3%) having at least one comorbidity related to obesity, which occurred in the following order: arthritis (60%), hypertension (56%), dyslipidemia (28%), sleep apnea (23%), hyperuricemia (16%), diabetes (12%), and polycystic ovarian syndrome (PCOS) (2.5%). One hundred and two patients underwent attempted LSG as a scheduled two-stage procedure for the LBPD-DS (Table 2). This is a prospective study of the initial 120 patients who underwent isolated LSG. Initially, the LSG was performed without a calibration [JUNE tube and resulted in high sleeve volumes (Group 1: n=25). In Group 2 (n=32) a calibration tube of 44 Fr was used and in Group 3 (n=63) a calibration tube of 32 Fr was used. The study group consists of 101 patients with high BMI, who were scheduled for a two-step LBPD-DS, but rejected the second step after one year. Study endpoints include estimated sleeve volume, volume of removed stomach, operative time, complication rates, length of hospital stay, changes in comorbidities, percentage of excess weight loss (%EWL) and changes in BMI (kg/m2). RESULTS All three groups were comparable regarding age, gender, and comorbidities. There was no hospital mortality, but one case of late mortality (0.8%). One male patient (237kg) developed renal failure after rhabdomyolysis and died nine months after surgery. 2008, SUPPLEMENT A] Bariatric Times 7
Table of Contents Feed for the Digital Edition of Bariatric Times - Supplement A - Covidien Bariatric Times - Supplement A - Covidien Contents Laparoscopic Sleeve Gastrectomy: From Magenstrasse And Mill To Sleeve Sleeve Gastrectomy Provides Resoultion of Type-2 Diabetes Without Duodenal Exclusion The Relationship Bewtween The Resected Remnant And Weight Loss Laparoscopic Sleeve Gastrectomy: Results After Two And Five Years Laparoscopic Sleeve Gastrectomy As An Initial Weight Loss Procedure For High-Risk Patients With Morbid Obesity Three-Year Results Of Laparoscopic Sleeve Gastrectomy In The Treatment Of Morbid Obesity In Korea Laparoscopic Sleeve Gastrectomy: Nutritional Concerns And PostOperative Dietary Care Laparoscopic Sleeve Gastrectomy: Prevention And Treatment Of Bleeding Prevention And Treatment Of Gerd/Hiatal Hernia And Stenosis Associated With Sleeve Gastrectomy Laparoscopic Revisions Of Sleeve Gastrectomy Survey Results Bariatric Times - Supplement A - Covidien Bariatric Times - Supplement A - Covidien - Bariatric Times - Supplement A - Covidien (Page 1) Bariatric Times - Supplement A - Covidien - Contents (Page 2) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy: From Magenstrasse And Mill To Sleeve (Page 3) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy: From Magenstrasse And Mill To Sleeve (Page 4) Bariatric Times - Supplement A - Covidien - Sleeve Gastrectomy Provides Resoultion of Type-2 Diabetes Without Duodenal Exclusion (Page 5) Bariatric Times - Supplement A - Covidien - Sleeve Gastrectomy Provides Resoultion of Type-2 Diabetes Without Duodenal Exclusion (Page 6) Bariatric Times - Supplement A - Covidien - The Relationship Bewtween The Resected Remnant And Weight Loss (Page 7) Bariatric Times - Supplement A - Covidien - The Relationship Bewtween The Resected Remnant And Weight Loss (Page 8) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy: Results After Two And Five Years (Page 9) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy: Results After Two And Five Years (Page 10) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy As An Initial Weight Loss Procedure For High-Risk Patients With Morbid Obesity (Page 11) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy As An Initial Weight Loss Procedure For High-Risk Patients With Morbid Obesity (Page 12) Bariatric Times - Supplement A - Covidien - Three-Year Results Of Laparoscopic Sleeve Gastrectomy In The Treatment Of Morbid Obesity In Korea (Page 13) Bariatric Times - Supplement A - Covidien - Three-Year Results Of Laparoscopic Sleeve Gastrectomy In The Treatment Of Morbid Obesity In Korea (Page 14) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy: Nutritional Concerns And PostOperative Dietary Care (Page 15) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy: Nutritional Concerns And PostOperative Dietary Care (Page 16) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy: Prevention And Treatment Of Bleeding (Page 17) Bariatric Times - Supplement A - Covidien - Laparoscopic Sleeve Gastrectomy: Prevention And Treatment Of Bleeding (Page 18) Bariatric Times - Supplement A - Covidien - Prevention And Treatment Of Gerd/Hiatal Hernia And Stenosis Associated With Sleeve Gastrectomy (Page 19) Bariatric Times - Supplement A - Covidien - Prevention And Treatment Of Gerd/Hiatal Hernia And Stenosis Associated With Sleeve Gastrectomy (Page 20) Bariatric Times - Supplement A - Covidien - Laparoscopic Revisions Of Sleeve Gastrectomy (Page 21) Bariatric Times - Supplement A - Covidien - Laparoscopic Revisions Of Sleeve Gastrectomy (Page 22) Bariatric Times - Supplement A - Covidien - Survey Results (Page 23) Bariatric Times - Supplement A - Covidien - Survey Results (Page 24)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.